Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PHARMACY PRICING SUIT SETTLEMENT ENSURES PRICING POLICY CHANGES WITHOUT INJUNCTION, PLAINTIFF LEAD LAWYERS MAINTAIN; FTC INVESTIGATING INDUSTRY PRICING

Executive Summary

The proposed $409 mil. settlement in pharmacy's class action antitrust lawsuit is sufficient to ensure that manufacturers will alter pricing practices that produced the litigation without an injunction, plaintiffs' attorney Michael Freed of the Chicago firm Much Shelist Freed Denenberg Ament Bell & Rubenstein told Chicago federal court Judge Charles Kocoras at a fairness hearing on the settlement March 27.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel